About
Overview
Management team
Board of directors
Investors
Scientific advisory board
Innovation
Overview
Pipeline
Technology
Clinical trials
Overview
LUCE-1
STELLA
CELESTE
For patients
Overview
Usher 1B
Stargardt
Expanded access
News
Careers
Overview
Corporate values
Recruitment companies
Contact
EN
English
Italiano
Search
News
News
Filter by:
All categories
All categories
Press Release
Publication
All disease areas
All disease areas
Stargardt
Usher 1B
Other
By year:
All years
All years
2025
2024
2023
2022
2021
2019
2014
Reset
12.08.2025
Press Release
Stargardt
AAVantgarde Bio Announces FDA Fast Track Designation for AAVB-039 for the Treatment of Stargardt Disease
15.07.2025
Press Release
Stargardt
AAVantgarde Receives FDA IND Clearance to Progress Stargardt Disease program AAVB-039
12.05.2025
Press Release
Usher 1B
AAVantgarde presents updated data of Usher 1B and STGD programs at ARVO 2025
28.04.2025
Press Release
Rasmus Holm-Jorgensen appointed CFO at AAVantgarde
31.03.2025
Press Release
Stargardt
AAVantgarde and TIGEM Publish Groundbreaking Research in Science Advances
10.03.2025
Press Release
Usher 1B
AAVantgarde announces 2 presentations at ARVO 2025
